From regulatory approvals to launch: a comparison of time to market between the US and EU5 April 27, 2021 Read More
How has COVID-19 affected payers regarding orphan drugs? Opportunity or threat? June 16, 2020 Read More
COVID-19 EU5 Payer Survey May 15, 2020 With this EU5 report we augment our recent US payer surveys to better understand COVID-19’s current and future impact on the global payer community. Read More
